US20100241228A1 - Engineered osteochondral construct for treatment of articular cartilage defects - Google Patents

Engineered osteochondral construct for treatment of articular cartilage defects Download PDF

Info

Publication number
US20100241228A1
US20100241228A1 US12/696,366 US69636610A US2010241228A1 US 20100241228 A1 US20100241228 A1 US 20100241228A1 US 69636610 A US69636610 A US 69636610A US 2010241228 A1 US2010241228 A1 US 2010241228A1
Authority
US
United States
Prior art keywords
chondrocytes
implant
construct
cartilage
demineralized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/696,366
Inventor
Carina Syring
Rudiger Walter Arthur von Versen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Musculoskeletal Transplant Foundation
Original Assignee
Musculoskeletal Transplant Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Musculoskeletal Transplant Foundation filed Critical Musculoskeletal Transplant Foundation
Priority to US12/696,366 priority Critical patent/US20100241228A1/en
Assigned to MUSCULOSKELETAL TRANSPLANT FOUNDATION reassignment MUSCULOSKELETAL TRANSPLANT FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SYRING, CARINA
Assigned to MUSCULOSKELETAL TRANSPLANT FOUNDATION reassignment MUSCULOSKELETAL TRANSPLANT FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VON VERSEN, RUDIGER WALTER ARTHUR
Publication of US20100241228A1 publication Critical patent/US20100241228A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608Bone, e.g. demineralised bone matrix [DBM], bone powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645Connective tissue
    • A61L27/3654Cartilage, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817Cartilage-forming cells, e.g. pre-chondrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843Connective tissue
    • A61L27/3852Cartilage, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655Chondrocytes; Cartilage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/10Mineral substrates
    • C12N2533/18Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells

Definitions

  • the present invention is generally directed towards the treatment of articular cartilage defects using an allograft bone scaffold or carrier.
  • the allograft bone is treated with allograft chondrocytes to form a cartilage surface on the allograft bone.
  • Chondrocytes are cells specific to articular cartilage. The isolation and cultivation of chondrocytes is a standard procedure, which has been undertaken for more than 10 years. Under two-dimensional culture conditions in cell culture vessels, chondrocytes dedifferentiate to fibroblast-like cells. During the dedifferentiation they lose their typical properties (grade of differentiation, cell form, synthesis of cartilage-specific matrix components), which are essential for physiology and biomechanics of cartilage.
  • the technique of autologous chondrocyte transplantation is very complex and requires postoperative immobilization of the patient.
  • the surgical site cannot bear load post surgery because the transplanted chondrocytes have to reach their original biological state (redifferentiation of in vitro dedifferentiated cells), then have to anchor to the defect, synthesize the cartilage-specific matrix and rebuild a new cartilage.
  • cartilage-bone cylinders are removed from non-load-bearing joint areas of the patient and transplanted into the defect.
  • This method shows good clinical results including a good load capacity of the operated knee-joint, but is only applicable to small cartilage defects due to the limited availability of autologous osteochondral cylinders.
  • Classical operation techniques which do not use cartilage or chondrocyte transplantation (abrasion, debridement, Pridie-drilling), result only in a defect repair with fibrous, less load-bearing tissue unfortunately. Additionally, repeated treatment is necessary as this tissue degenerates over time.
  • Osteochondral transplantation or mosaicplasty involves excising all injured or unstable tissue from the articular defect and creating cylindrical holes in the base of the defect and underlying bone. These holes are filled with autologous cylindrical plugs of healthy cartilage and bone in a mosaic fashion. The osteochondral plugs are harvested from a lower weight-bearing area of lesser importance in the same joint. Reports of results of osteochondral plug autografts in a small number of patients indicate that they decrease pain and improve joint function, however, long-term results have not been reported.
  • Factors that can compromise the results include donor site morbidity, effects of joint incongruity on the opposing surface of the donor site, damage to the chondrocytes at the articular margins of the donor and recipient sites during preparation and implantation, and collapse or settling of the graft over time.
  • the limited availability of sites for harvest of osteochondral autografts restricts the use of this approach to treatment of relatively small articular defects and the healing of the chondral portion of the autograft to the adjacent articular cartilage remains a concern.
  • Carticel® is a commercial process to culture the patient's own cartilage cells for use in the repair of cartilage defects in the knee joint marketed by Genzyme Biosurgery in the United States and Europe.
  • the procedure uses arthroscopy to take a biopsy from a healthy, less loaded area of articular cartilage. Enzymatic digestion of the harvested tissue releases the cells that are sent to a laboratory where they are grown for a period ranging from 2-5 weeks to achieve a 10 fold increase in cell mass.
  • the autologous cells are injected during an open and extensive knee procedure into areas of defective cartilage where it is hoped that they will facilitate the repair of damaged tissue.
  • An autologous periosteal flap with cambium layer facing down is used to seal the transplanted cells in place and act as a mechanical barrier. Fibrin glue is used to seal the edges of the flap. This technique preserves the subchondral bone plate. Proponents of this procedure report that it produces satisfactory results, including the ability to return to demanding physical activities, in more than 80% of patients and that biopsy specimens of the tissue in the graft sites show hyaline-like cartilage repair. However, long term studies of this procedure in rabbits and dogs showed limited success and showed degradation at the implant site.
  • the graft is then morselized in a bone graft crusher, mixing the articular cartilage with the cancellous bone.
  • the paste is then pushed into the defect and secured by the adhesive properties of the bleeding bone.
  • the paste can also be mixed with a cartilage stimulating factor, a plurality of cells, or a biological glue. All patients are kept non-weight bearing for four weeks and used a continuous passive motion machine for six hours each night. Histologic appearance of the biopsies have mainly shown a mixture of fibrocartilage with hyaline cartilage. Concerns associated with this method are harvest site morbidity and availability, similar to the mosaicplasty method.
  • U.S. Pat. No. 6,379,367 issued Apr. 30, 2002 discloses a plug with a base membrane, a control plug, and a top membrane which overlies the surface of the cartilage covering the defective area of the joint.
  • U.S. Pat. No. 6,488,033 issued Dec. 3, 2002 discloses an allograft plug with a cartilage cap which is surface contour matched to the surface of a condyle defect area which is to be replaced.
  • the allograft plug is transplanted in an interference fit within the cavity site which remains after a condylar defect is removed from a patients condyle.
  • the present implant and method differs from the above prior art in that it is directed to allograft chondrocyte transplantation on an allograft cancellous bone carrier to provide an implant for cartilage transplantation.
  • the present method utilizes techniques of autograft and/or allograft chondrocyte transplantation onto a demineralized allograft cancellous bone implant structure to form an implant with a cartilage layer on the bone structure for use in cartilage repair on a patient at a later time.
  • FIG. 1 is a chart showing pH in the supernatants through a 44 day period
  • FIG. 2 is a chart showing calcium in the supernatants corrected by the calcium content of pure medium through a 44 day period
  • FIG. 3 is a chart showing phosphate in the supernatant corrected by the phosphate content of pure medium through a 44 day period.
  • Bone morphogenetic proteins from the cancellous bone plugs have a positive effect on chondrocyte differentiation in vitro by stimulating the formation of a native, chondrocyte-phenotype and proper matrix production by the cells.
  • the highest stimulation effect of BMP's on chondrocytes can be observed, if BMP's are immobilized onto a carrier or retained in a biological matrix. In these carriers the natural BMP's of the bone are released by the demineralization but retained in the carrier matrix.
  • different synthetic carrier materials were used, among them GB 14 (Ca 2 KNa(PO 4 ) 2 ), ceramics and hydroxyapatite.
  • chondrocytes were isolated from cartilage samples taken from donors by enzymatic digestion with collagenase, DNAse and hyaluronidase. Since the total number of chondrocytes and cell proliferation decrease with donor age, only donors younger than 50 years were used. Furthermore, bones having joint diseases and bone fractures were excluded from donor selection. After the enzymatic digestion, a suspension of chondrocytes was obtained and tested by trypan blue exclusion to determine the viability of the cell suspension. The suspension was seeded to standard cell culture vessels in order to expand the cells. Since serum is necessary for a good chondrocyte growth and maturation, the medium used contained 10% fetal calf serum. Ascorbic acid was added to stimulate the collagen production by the cells.
  • the redifferentiation potential of two-dimensionally expanded cells was tested by transferring them into a three-dimensional agarose gel. During expansion, the cells lost their original phenotype, forming fibroblast-like cells. After transferring them into the agarose gel, the normal, round chondrocyte phenotype could be observed, indicating that the cells were able to redifferentiate.
  • the chondrocytes were resuspended in 0.5% low melting agarose reaching a final density of 2 million cells/ml in order to increase the attachment on the carriers and was then seeded onto the following different carrier materials.
  • biologic carriers human cancellous bone, frozen, sterilized with peracetic acid, provided by the tissue bank of DIZG:
  • the demineralization process was done according to standard operations for demineralization of cancellous bone.
  • the cancellous cubes were washed in order to remove the cells and then dried at 37° C. for 36 hours.
  • the cubes (1 cm ⁇ 1 cm ⁇ 1 cm) were demineralized in 1 N HCl for 24 hours at room temperature.
  • the whole cancellous bone cube was incubated in this solution.
  • the front surface of the cube was immersed to 2 mm depth in the solution.
  • Approximately 2 mm of the surface of the cube was totally demineralized with a boundary layer between the fully demineralized section and the mineralized section being about 50 ⁇ m thick. Afterwards the cubes were washed with sterile water for injection until the pH was neutral.
  • the CaCO 3 /CaSO 4 (a1) carrier showed a rough surface that could be easily destroyed if touched with forceps. All other materials Ap40, GB 14 and 46CaO*23TiO 2 *31P 2 O 5 had a plain and stiff surface, which was not destroyed during manipulation. All synthetic carriers were sterilized prior to use at 186° C./2.5 hours.
  • a medium pH of 7.32 was measured during long-term incubation of CaCO 3 /CaSO 4 carrier. The long term incubation only lasted 16 days as no further incubation was possible because of degradation of carrier.
  • the carriers had a relatively high pH of more than 7.5 (7.52) detected after 44 days.
  • a pH of 7.5 was determined at days 4 and 7 followed thereafter by only physiological pH-values (pH 7.4).
  • Supernatants of Ap40 showed a physiological pH during the entire investigation increasing to 7.5 after 44 days.
  • Carriers that release particles are not suited for transplantation into the knee joint because of the potential induction of cartilage damage and joint dysfunction. Also, carriers with high disposal of calcium and phosphate are not useful because they may induce undesired chondrocyte calcification. Consequently, only Ap40 and 46CaO*23TiO 2 *31P 2 O 5 were used as non-biological carriers for establishing three-dimensional chondrocyte cultures.
  • Human chondrocytes were isolated by enzymatic digestion of human articular cartilage (donor age ⁇ 50 years, no degenerative defects of the knee joint, no fractures of the underlying bone). A high cell viability of >90%, in many cases 100%, was measured after the isolation.
  • the cells were cultivated in medium without further supplementation with growth factors. The medium was changed every third day. A good cell adhesion on the cultures vessels (cell culture flasks) was observed after 7 days of incubation at 37° C. and 5% CO 2 . Growth kinetics showed that the population doubling time as well as the lag time were increased with increasing passage of the cells. The chondrocytes showed a dedifferentiated, fibroblast-like phenotype in two-dimensional culture.
  • the redifferentiation potential of the dedifferentiated chondrocytes was evaluated in 3D agarose cultures where the typical round cell form was observed (original chondrocyte phenotype, sign of redifferention of dedifferentiated cells).
  • the different carriers were fixed to the culture vessels (24 well plates) by sealing with 4% low melting agarose.
  • the surfaces of the carriers were prepared for cell seeding by coating with poly-L-lysine (incubation 1 hour, non-bound lysine removed by washing).
  • the chondrocytes taken from both live and deceased donors were resuspended in 2% low melting agarose and incubated in the refrigerator for 7 minutes in order to obtain a more viscous suspension.
  • the top of each carrier was overlaid with this viscous cell suspension.
  • the seeded carriers were then transferred into the refrigerator for 15 minutes to allow for gelation. This was followed by a 1-hour incubation in the incubator (37° C., 5% CO 2 ). Afterwards, each vessel was supplied with culture medium. All cultures were incubated for 40 days and the medium was changed every third day.
  • Ap40 and 46CaO*23TiO 2 *31P 2 O 5 -ceramic were used for the establishment of three-dimensional chondrocyte cultures.
  • Ap40 showed a pH increase as well as increases in calcium in the supernatant.
  • 46CaO*23TiO 2 *31P 2 O 5 showed an increase in the phosphate in the supernatant.
  • Fibroblast-like, dedifferentiated cells were observed at the surfaces of these materials after 15 days incubation, however, the majority of the surface was not covered by cells. The cells formed only a single layer and were not surrounded by significant amounts of extracellular matrix. The amount of cells did not increase in the following culture period and there was no macroscopic sign of neocartilage formation on these carriers.
  • the range of cell density i.e., cells per ml, or cells per cm 3
  • the cells showed a chondrocyte-like, round appearance.
  • the chondrocytes covered the entire carrier surface and were surrounded by significant amounts of extracellular matrix.
  • a multi-layer growth and formation of cell clusters could be detected.
  • the multilayer chondrocyte growth was about 4 layers high forming a cartilage layer approximately 2.0 mm thick with a cell density of approximately 10 million cells per cm 3 .
  • articular cartilage which is 2-5 mm.
  • the chondrocytes are not arranged in multilayers, but in stacks of 1 to 8 cells, and the cellularity per amount of tissue is lower.
  • partially demineralized cancellous carriers a neo-cartilage formation could be observed macroscopically by appearance of a white opalescent capsule which was stable if impressed with forceps. In all other carriers this capsule formation was not noticeable macroscopically.

Abstract

An implant for articular cartilage repair includes (1) a three-dimensional body formed of cancellous bone having a demineralized section that contains bone morphogenetic proteins (BMP's) that are released by the demineralization but retained in the body, and (2) a cartilage layer formed on a surface of the demineralized section. The cartilage layer is formed by a method including the steps of (a) isolating chondrocytes from articular cartilage of a donor; (b) cultivating the isolated chondrocytes in a medium; (c) adding the cultivated chondrocytes to the demineralized section of the body, whereby the cultivated chondrocytes are stimulated by the BMP's retained in the body; and (d) incubating the cultivated chondrocytes to form a plurality of layers of chondrocytes on the demineralized section, wherein the plurality of layers of chondrocytes forms the cartilage layer.

Description

    RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 11/481,955, filed Jul. 7, 2006, and claims the priority of U.S. Provisional Application Ser. No. 60/697,563, filed Jul. 11, 2005. The disclosure of each of the applications identified above is incorporated herein by reference in its entirety for all purposes.
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • Not applicable.
  • REFERENCE TO SEQUENCE LISTING, A TABLE OR A COMPUTER PROGRAM LISTING COMPACT DISC APPENDIX
  • None.
  • FIELD OF INVENTION
  • The present invention is generally directed towards the treatment of articular cartilage defects using an allograft bone scaffold or carrier. In particular, the allograft bone is treated with allograft chondrocytes to form a cartilage surface on the allograft bone.
  • BACKGROUND OF THE INVENTION
  • Chondrocytes are cells specific to articular cartilage. The isolation and cultivation of chondrocytes is a standard procedure, which has been undertaken for more than 10 years. Under two-dimensional culture conditions in cell culture vessels, chondrocytes dedifferentiate to fibroblast-like cells. During the dedifferentiation they lose their typical properties (grade of differentiation, cell form, synthesis of cartilage-specific matrix components), which are essential for physiology and biomechanics of cartilage.
  • For many years there have been attempts to transplant dedifferentiated chondrocytes grown under two-dimensional culture conditions into human joint defects. Transplantation of cells grown in culture provides another method of introducing a new cell population into chondral and osteochondral defects. The procedure uses arthroscopy to take a biopsy from a healthy, less loaded area of articular cartilage. Enzymatic digestion of the harvested tissue releases the cells that are sent to a laboratory where they are grown. Once cultivated, they are injected during a more open and extensive knee procedure into areas of defective cartilage in an attempt to facilitate the repair of damaged tissue.
  • The technique of autologous chondrocyte transplantation is very complex and requires postoperative immobilization of the patient. The surgical site cannot bear load post surgery because the transplanted chondrocytes have to reach their original biological state (redifferentiation of in vitro dedifferentiated cells), then have to anchor to the defect, synthesize the cartilage-specific matrix and rebuild a new cartilage.
  • In the procedure of mosaicplasty (autologous cartilage transplantation), cartilage-bone cylinders are removed from non-load-bearing joint areas of the patient and transplanted into the defect. This method shows good clinical results including a good load capacity of the operated knee-joint, but is only applicable to small cartilage defects due to the limited availability of autologous osteochondral cylinders. Classical operation techniques, which do not use cartilage or chondrocyte transplantation (abrasion, debridement, Pridie-drilling), result only in a defect repair with fibrous, less load-bearing tissue unfortunately. Additionally, repeated treatment is necessary as this tissue degenerates over time.
  • Osteochondral transplantation or mosaicplasty involves excising all injured or unstable tissue from the articular defect and creating cylindrical holes in the base of the defect and underlying bone. These holes are filled with autologous cylindrical plugs of healthy cartilage and bone in a mosaic fashion. The osteochondral plugs are harvested from a lower weight-bearing area of lesser importance in the same joint. Reports of results of osteochondral plug autografts in a small number of patients indicate that they decrease pain and improve joint function, however, long-term results have not been reported. Factors that can compromise the results include donor site morbidity, effects of joint incongruity on the opposing surface of the donor site, damage to the chondrocytes at the articular margins of the donor and recipient sites during preparation and implantation, and collapse or settling of the graft over time. The limited availability of sites for harvest of osteochondral autografts restricts the use of this approach to treatment of relatively small articular defects and the healing of the chondral portion of the autograft to the adjacent articular cartilage remains a concern.
  • As previously noted, transplantation of cells grown in culture provides another method of introducing a new cell population into chondral and osteochondral defects. Carticel® is a commercial process to culture the patient's own cartilage cells for use in the repair of cartilage defects in the knee joint marketed by Genzyme Biosurgery in the United States and Europe. The procedure uses arthroscopy to take a biopsy from a healthy, less loaded area of articular cartilage. Enzymatic digestion of the harvested tissue releases the cells that are sent to a laboratory where they are grown for a period ranging from 2-5 weeks to achieve a 10 fold increase in cell mass. Once cultivated, the autologous cells are injected during an open and extensive knee procedure into areas of defective cartilage where it is hoped that they will facilitate the repair of damaged tissue. An autologous periosteal flap with cambium layer facing down is used to seal the transplanted cells in place and act as a mechanical barrier. Fibrin glue is used to seal the edges of the flap. This technique preserves the subchondral bone plate. Proponents of this procedure report that it produces satisfactory results, including the ability to return to demanding physical activities, in more than 80% of patients and that biopsy specimens of the tissue in the graft sites show hyaline-like cartilage repair. However, long term studies of this procedure in rabbits and dogs showed limited success and showed degradation at the implant site. The original study report has been criticized for not being a prospective controlled randomized study and for lack of quantitative or mechanical data. Of interest, a 14 year follow-up of a similar patient group that underwent diagnostic arthroscopy in combination with one of several treatments (removal of bone bodies, shaving, Pridie drilling) had good to excellent knee function in 78% of the patients. Thus, further studies are needed to assess the function and durability of the new tissue to determine whether it improves joint function and delays or prevents joint degeneration.
  • As with the perichondrial graft, patient/donor age may compromise the success of this procedure as the chondrocyte population decreases with increasing age. Disadvantages to this procedure include the need for two separate surgical procedures, potential damage to surrounding cartilage when the periosteal patch is sutured in place, the requirement of demanding microsurgical techniques, and the expensive cost of the procedure which is currently not covered by insurance.
  • The use of implants for cartilage defects is much more limited than that for bone defects. Aside from the fresh allograft implants and autologous implants, U.S. Pat. No. 6,110,209 issued Nov. 5, 1998 shows the use of an autologous articular cartilage cancellous bone paste to fill arthritic defects. The surgical technique is arthroscopic and includes debriding (shaving away loose or fragmented articular cartilage), followed by morselizing the base of the arthritic defect with an awl until bleeding occurs. An osteochondral graft is then harvested from the inner rim of the intercondylar notch using a trephine. The graft is then morselized in a bone graft crusher, mixing the articular cartilage with the cancellous bone. The paste is then pushed into the defect and secured by the adhesive properties of the bleeding bone. The paste can also be mixed with a cartilage stimulating factor, a plurality of cells, or a biological glue. All patients are kept non-weight bearing for four weeks and used a continuous passive motion machine for six hours each night. Histologic appearance of the biopsies have mainly shown a mixture of fibrocartilage with hyaline cartilage. Concerns associated with this method are harvest site morbidity and availability, similar to the mosaicplasty method.
  • U.S. Pat. No. 6,379,367 issued Apr. 30, 2002 discloses a plug with a base membrane, a control plug, and a top membrane which overlies the surface of the cartilage covering the defective area of the joint.
  • U.S. Pat. No. 6,488,033 issued Dec. 3, 2002 discloses an allograft plug with a cartilage cap which is surface contour matched to the surface of a condyle defect area which is to be replaced. The allograft plug is transplanted in an interference fit within the cavity site which remains after a condylar defect is removed from a patients condyle.
  • The present implant and method differs from the above prior art in that it is directed to allograft chondrocyte transplantation on an allograft cancellous bone carrier to provide an implant for cartilage transplantation.
  • SUMMARY OF THE INVENTION
  • The present method utilizes techniques of autograft and/or allograft chondrocyte transplantation onto a demineralized allograft cancellous bone implant structure to form an implant with a cartilage layer on the bone structure for use in cartilage repair on a patient at a later time.
  • It is an object of the invention to use allograft cancellous bone as a carrier on which to grow a cartilage layer for use in cartilage repair.
  • It is an object of the invention to provide an autograft and/or allograft implant for joints which provides pain relief, restores normal function and will postpone or alleviate the need for prosthetic replacement.
  • It is also an object of the invention to provide a cartilage repair implant which is easily placed in a defect area by the surgeon using an arthroscopic, minimally invasive technique.
  • It is further an object of the invention to provide an allograft implant procedure which is applicable for both partial and full thickness lesions.
  • It is yet another object of the invention to provide a cartilage implant which can be uniformly used for any patient.
  • These and other objects, advantages, and novel features of the present invention will become apparent when considered with the teachings contained in the detailed disclosure along with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a chart showing pH in the supernatants through a 44 day period;
  • FIG. 2 is a chart showing calcium in the supernatants corrected by the calcium content of pure medium through a 44 day period; and
  • FIG. 3 is a chart showing phosphate in the supernatant corrected by the phosphate content of pure medium through a 44 day period.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention is susceptible of embodiment in various forms as will hereinafter be described with the understanding that the present disclosure is to be considered as an exemplification of the invention, and is not intended to limit the invention to the specific embodiments disclosed herein.
  • Sterile cancellous bone replacement structures were utilized for the in vitro grown cartilage replacements, which allow the fabrication of load-bearing constructs. Bone morphogenetic proteins (“BMP's”) from the cancellous bone plugs have a positive effect on chondrocyte differentiation in vitro by stimulating the formation of a native, chondrocyte-phenotype and proper matrix production by the cells. The highest stimulation effect of BMP's on chondrocytes can be observed, if BMP's are immobilized onto a carrier or retained in a biological matrix. In these carriers the natural BMP's of the bone are released by the demineralization but retained in the carrier matrix. For evaluating the effect of the biological carrier structure of cancellous bone on chondrocyte growth, different synthetic carrier materials were used, among them GB 14 (Ca2KNa(PO4)2), ceramics and hydroxyapatite.
  • In order to develop the in vitro manufactured cartilage constructs, chondrocytes were isolated from cartilage samples taken from donors by enzymatic digestion with collagenase, DNAse and hyaluronidase. Since the total number of chondrocytes and cell proliferation decrease with donor age, only donors younger than 50 years were used. Furthermore, bones having joint diseases and bone fractures were excluded from donor selection. After the enzymatic digestion, a suspension of chondrocytes was obtained and tested by trypan blue exclusion to determine the viability of the cell suspension. The suspension was seeded to standard cell culture vessels in order to expand the cells. Since serum is necessary for a good chondrocyte growth and maturation, the medium used contained 10% fetal calf serum. Ascorbic acid was added to stimulate the collagen production by the cells.
  • The redifferentiation potential of two-dimensionally expanded cells was tested by transferring them into a three-dimensional agarose gel. During expansion, the cells lost their original phenotype, forming fibroblast-like cells. After transferring them into the agarose gel, the normal, round chondrocyte phenotype could be observed, indicating that the cells were able to redifferentiate. The chondrocytes were resuspended in 0.5% low melting agarose reaching a final density of 2 million cells/ml in order to increase the attachment on the carriers and was then seeded onto the following different carrier materials.
  • I. Evaluation of Different Carrier Materials for Chondrocyte Cultures
  • The following synthetic carriers (bone replacement materials) were investigated:
      • a1) CaCO3/CaSO4
      • a2) Ap40 (Apatite), slurry 6.89 μm
      • a3) GB 14
      • a4) 46CaO*23TiO2*31P2O5
  • The following biologic carriers were evaluated (human cancellous bone, frozen, sterilized with peracetic acid, provided by the tissue bank of DIZG):
      • b1) B0/1, donor 432/98, 54 y., cancellous bone from tibia plateau not demineralized
      • b2) B1/1 totally demineralized
      • b3) B2/1 superficially (surface) demineralized
      • b4) B0/2 donor 432/98, 54 y., cancellous bone from femur epiphysis not demineralized
      • b5) B1/2 totally demineralized
      • b6) B2/2 superficially (surface) demineralized
      • b7) C0/2 donor 430/98, 60 y., cancellous bone from vertebral column not demineralized
      • b8) C1/2 totally demineralized
      • b9) C2/2 superficially (surface) demineralized
  • The demineralization process was done according to standard operations for demineralization of cancellous bone. The cancellous cubes were washed in order to remove the cells and then dried at 37° C. for 36 hours. The cubes (1 cm×1 cm×1 cm) were demineralized in 1 N HCl for 24 hours at room temperature. For the totally demineralized cubes, the whole cancellous bone cube was incubated in this solution. In the case of the partially demineralized bone only the front surface of the cube was immersed to 2 mm depth in the solution. Approximately 2 mm of the surface of the cube was totally demineralized with a boundary layer between the fully demineralized section and the mineralized section being about 50 μm thick. Afterwards the cubes were washed with sterile water for injection until the pH was neutral.
  • II. Macroscopic and Microscopic Evaluation of the Carriers
  • The CaCO3/CaSO4 (a1) carrier showed a rough surface that could be easily destroyed if touched with forceps. All other materials Ap40, GB 14 and 46CaO*23TiO2*31P2O5 had a plain and stiff surface, which was not destroyed during manipulation. All synthetic carriers were sterilized prior to use at 186° C./2.5 hours.
  • The totally and superficially demineralized cancellous bones cubes (b1-9) also showed no differences in material resistance (resistance investigated by test with forceps, qualitative evaluation). Both materials had a soft and spongy appearance.
  • Large pores in the range of 10-100 μm were observed in all cancellous samples (b1-9) during microscopic evaluation. The pore size represented a multiple of the cell volume of a chondrocyte. Samples obtained from vertebral column had a lower pore size than all other preparations. However, no particular bone tissue; namely, tibia, femur, vertebral column appeared to have superior or inferior chondrocyte growth capacities to the other.
  • III. Long-Term Incubation of the Carrier Materials
  • Both synthetic and allograft cancellous carriers were incubated under cell culture conditions in order to evaluate their long-term stability (incubation in Ham's F12 medium at 37° C., 6 weeks, no addition of cells). The pH as well as the calcium and phosphate concentrations were measured in the supernatants every third day.
  • No structural changes were detected after the 6 week incubation of Ap40 (a2) and 46CaO*23TiO2*31P2O5 (a4). White, crystalline sediments were observed in the medium after 44 days of incubation from the carrier GB 14. The CaCO3/CaSO4 carrier exhibited dramatic structural changes and volume reduction under incubation at cell culture conditions. The process of material destruction started after 3 days of incubation and was accompanied by a large amount of particle release into the medium.
  • A medium pH of 7.32 was measured during long-term incubation of CaCO3/CaSO4 carrier. The long term incubation only lasted 16 days as no further incubation was possible because of degradation of carrier. In supernatants of GB 14, the carriers had a relatively high pH of more than 7.5 (7.52) detected after 44 days. In the case of 46CaO*23TiO2*31P2O5-ceramic a pH of 7.5 was determined at days 4 and 7 followed thereafter by only physiological pH-values (pH 7.4). Supernatants of Ap40 showed a physiological pH during the entire investigation increasing to 7.5 after 44 days.
  • A release of calcium into the medium was observed during incubation of CaCO3/CaSO4, Ap40 and GB 14 carriers (calcium release of CaCO3/CaSO4>Ap40>GB 14). Additionally, high amounts of phosphate were detected in supernatants from GB 14 carriers with an increase in phosphate in 46CaO*23TiO2*31P2O5 carriers.
  • Carriers that release particles are not suited for transplantation into the knee joint because of the potential induction of cartilage damage and joint dysfunction. Also, carriers with high disposal of calcium and phosphate are not useful because they may induce undesired chondrocyte calcification. Consequently, only Ap40 and 46CaO*23TiO2*31P2O5 were used as non-biological carriers for establishing three-dimensional chondrocyte cultures.
  • After 6 weeks of incubation of the biological carriers (cancellous bone tissue forms), there was no evidence of structural changes, volume reduction or release of calcium or phosphate. Only physiological pH values (pH 7.4) were measured in the supernatants during long-term incubation of the cancellous bone samples. All biological carriers did not release significant amounts of calcium or phosphate to the medium. There were no significant pH changes observed if the bone cubes were submitted to along term incubation in medium and the final pH reached physiological values of approximately pH 7.4 after 44 days of incubation.
  • IV. Isolation and Cultivation of Human Chondrocytes
  • Human chondrocytes were isolated by enzymatic digestion of human articular cartilage (donor age <50 years, no degenerative defects of the knee joint, no fractures of the underlying bone). A high cell viability of >90%, in many cases 100%, was measured after the isolation.
  • The cells were cultivated in medium without further supplementation with growth factors. The medium was changed every third day. A good cell adhesion on the cultures vessels (cell culture flasks) was observed after 7 days of incubation at 37° C. and 5% CO2. Growth kinetics showed that the population doubling time as well as the lag time were increased with increasing passage of the cells. The chondrocytes showed a dedifferentiated, fibroblast-like phenotype in two-dimensional culture.
  • The redifferentiation potential of the dedifferentiated chondrocytes was evaluated in 3D agarose cultures where the typical round cell form was observed (original chondrocyte phenotype, sign of redifferention of dedifferentiated cells).
  • V. Development of Three-Dimensional Chondrocyte Cultures
  • The different carriers were fixed to the culture vessels (24 well plates) by sealing with 4% low melting agarose. The surfaces of the carriers were prepared for cell seeding by coating with poly-L-lysine (incubation 1 hour, non-bound lysine removed by washing). The chondrocytes taken from both live and deceased donors were resuspended in 2% low melting agarose and incubated in the refrigerator for 7 minutes in order to obtain a more viscous suspension. The top of each carrier was overlaid with this viscous cell suspension. The seeded carriers were then transferred into the refrigerator for 15 minutes to allow for gelation. This was followed by a 1-hour incubation in the incubator (37° C., 5% CO2). Afterwards, each vessel was supplied with culture medium. All cultures were incubated for 40 days and the medium was changed every third day.
  • Because of the low material stability of all other synthetic materials only Ap40 and 46CaO*23TiO2*31P2O5-ceramic were used for the establishment of three-dimensional chondrocyte cultures. Ap40 showed a pH increase as well as increases in calcium in the supernatant. 46CaO*23TiO2*31P2O5 showed an increase in the phosphate in the supernatant. Fibroblast-like, dedifferentiated cells were observed at the surfaces of these materials after 15 days incubation, however, the majority of the surface was not covered by cells. The cells formed only a single layer and were not surrounded by significant amounts of extracellular matrix. The amount of cells did not increase in the following culture period and there was no macroscopic sign of neocartilage formation on these carriers.
  • There was a significant colonization of the osteobiological carriers (cancellous bone) with chondrocytes detectable after 40 days incubation. The range of cell density (i.e., cells per ml, or cells per cm3) will provide attachment on the osteobiological carrier in a range from between 0.2 to 10 million cells per ml, or cells per cm3. The cells showed a chondrocyte-like, round appearance. The chondrocytes covered the entire carrier surface and were surrounded by significant amounts of extracellular matrix. A multi-layer growth and formation of cell clusters could be detected. The multilayer chondrocyte growth was about 4 layers high forming a cartilage layer approximately 2.0 mm thick with a cell density of approximately 10 million cells per cm3. This compares to the thickness of articular cartilage which is 2-5 mm. In articular cartilage, the chondrocytes are not arranged in multilayers, but in stacks of 1 to 8 cells, and the cellularity per amount of tissue is lower. In the case of partially demineralized cancellous carriers, a neo-cartilage formation could be observed macroscopically by appearance of a white opalescent capsule which was stable if impressed with forceps. In all other carriers this capsule formation was not noticeable macroscopically.
  • The principles, preferred embodiments and modes of operation of the present invention have been described in the foregoing specification. However, the invention should not be construed as limited to the particular embodiments which have been described above. Instead, the embodiments described here should be regarded as illustrative rather than restrictive. Variations and changes may be made by others without departing from the scope of the present invention as defined by the following claims:

Claims (37)

1. An implant for articular cartilage repair, comprising a three-dimensional body formed of cancellous bone and having a demineralized section, the demineralized section containing bone morphogenetic proteins (BMP's) that are released by the demineralization but retained in said body, and a cartilage layer formed on a surface of the demineralized section, said cartilage layer being formed by a method including the steps of:
(a) isolating chondrocytes from articular cartilage of a donor;
(b) cultivating the isolated chondrocytes in a medium;
(c) adding the cultivated chondrocytes to the demineralized section of said body, whereby the cultivated chondrocytes are stimulated by the BMP's retained in said body; and
(d) incubating the cultivated chondrocytes to form a plurality of layers of chondrocytes on the demineralized section, wherein the plurality of layers of chondrocytes forms said cartilage layer.
2. The implant as claimed in claim 1, wherein the plurality of layers of chondrocytes includes four layers.
3. The implant as claimed in claim 1, wherein the chondrocytes are allograft chondrocytes.
4. The implant as claimed in claim 3, wherein the donor is less than 50 years of age.
5. The implant as claimed in claim 3, wherein the donor is alive.
6. The implant as claimed in claim 3, wherein the donor is deceased.
7. The implant as claimed in claim 1, wherein the chondrocytes are autograft chondrocytes.
8. The implant as claimed in claim 1, wherein said body is formed of allograft cancellous bone.
9. The implant as claimed in claim 1, wherein step (b) includes placing the surface of the demineralized section in a culture vessel and preparing the surface of the demineralized section for cell seeding.
10. The implant as claimed in claim 1, wherein step (d) is performed until said cartilage layer has a thickness in a range of from 2 mm to 5 mm.
11. The implant as claimed in claim 1, wherein said body includes pores having a size that represents a multiple of the cell volume of a chondrocyte.
12. The implant as claimed in claim 1, wherein step (d) is performed for a period of at least 40 days.
13. The implant as claimed in claim 1, wherein the cell density of the chondrocytes in said cartilage layer is about 10 million cells per cm3.
14. The implant as claimed in claim 1, wherein all of said body is demineralized.
15. The implant as claimed in claim 1, wherein the demineralized section has a depth of approximately 2 mm.
16. The implant as claimed in claim 15, wherein said body includes a mineralized section and a boundary layer formed between the demineralized section and the mineralized section, the boundary layer having a thickness of about 50 microns.
17. The implant as claimed in claim 1, wherein said body includes pores having a size that ranges from 10 to 100 microns.
18. The implant as claimed in claim 1, wherein step (b) includes expanding the chondrocytes in a two-dimensional culture until the chondrocytes show a dedifferentiated fibroblast-like phenotype.
19. The implant as claimed in claim 1, wherein step (d) is performed until said cartilage layer has a thickness of approximately 2.0 mm.
20. A construct for repairing an articular cartilage defect, said construct comprising a body entirely formed from substantially demineralized bone.
21. The construct as claimed in claim 20, wherein said body contains bone morphogenetic proteins (BMPs).
22. The construct as claimed in claim 20, wherein said body is porous.
23. The construct as claimed in claim 22, wherein said body includes pores having a size that represents a multiple of the cell volume of a chondrocyte.
24. The construct as claimed in claim 22, wherein said pores have a size that ranges from 10 to 100 microns.
25. The construct as claimed in claim 20, wherein said body is sterile.
26. The construct as claimed in claim 20, wherein said body is spongy.
27. The construct as claimed in claim 20, wherein said body is formed from allograft bone.
28. The construct as claimed in claim 20, wherein said body has at least one surface which contains chondrocytes.
29. The construct as claimed in claim 28, wherein said chondrocytes are allograft chondrocytes.
30. The construct as claimed in claim 28, wherein said chondrocytes have a cell density that ranges from about 0.2 million to about 10 million cells per cm3.
31. The construct as claimed in claim 28, wherein said chondrocytes cover the entirety of said at least one surface of said body.
32. The construct as claimed in claim 31, further comprising an extracellular matrix that surrounds said chondrocytes.
33. The construct as claimed in claim 31, further comprising at least one cartilage layer overlying said at least one surface.
34. The construct as claimed in claim 33, wherein said cartilage layer has a thickness of approximately 2 millimeters.
35. The A construct as claimed in claim 33, wherein said at least one cartilage layer has a cell density that ranges from about 0.2 million to about 10 million cells per cm3.
36. The construct as claimed in claim 31, further comprising a multiplicity of cartilage layers overlying said at least one surface of said body.
37. The construct as claimed in claim 36, wherein said multiplicity of cartilage layers has a thickness of approximately 2 millimeters.
US12/696,366 2006-07-07 2010-01-29 Engineered osteochondral construct for treatment of articular cartilage defects Abandoned US20100241228A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/696,366 US20100241228A1 (en) 2006-07-07 2010-01-29 Engineered osteochondral construct for treatment of articular cartilage defects

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/481,955 US7815926B2 (en) 2005-07-11 2006-07-07 Implant for articular cartilage repair
US12/696,366 US20100241228A1 (en) 2006-07-07 2010-01-29 Engineered osteochondral construct for treatment of articular cartilage defects

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/481,955 Continuation US7815926B2 (en) 2005-07-11 2006-07-07 Implant for articular cartilage repair

Publications (1)

Publication Number Publication Date
US20100241228A1 true US20100241228A1 (en) 2010-09-23

Family

ID=42738326

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/481,955 Active 2028-04-01 US7815926B2 (en) 2005-07-11 2006-07-07 Implant for articular cartilage repair
US12/696,366 Abandoned US20100241228A1 (en) 2006-07-07 2010-01-29 Engineered osteochondral construct for treatment of articular cartilage defects

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/481,955 Active 2028-04-01 US7815926B2 (en) 2005-07-11 2006-07-07 Implant for articular cartilage repair

Country Status (1)

Country Link
US (2) US7815926B2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102078642A (en) * 2011-01-19 2011-06-01 北京大学第三医院 Articular cartilage restoration and regeneration stent and preparation method thereof
USRE43258E1 (en) 2003-04-29 2012-03-20 Musculoskeletal Transplant Foundation Glue for cartilage repair
US8292968B2 (en) 2004-10-12 2012-10-23 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8906110B2 (en) 2007-01-24 2014-12-09 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US9289452B2 (en) 2013-03-07 2016-03-22 Allosource Consistent calcium content bone allograft systems and methods
US9364328B2 (en) 2011-11-17 2016-06-14 Allosource Multi-piece machine graft systems and methods
US9603710B2 (en) 2013-03-15 2017-03-28 Allosource Methods of manufacturing perforated osteochondral allograft compositions
US9701940B2 (en) 2005-09-19 2017-07-11 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US9730796B2 (en) 2014-05-16 2017-08-15 Allosource Composite bone constructs and methods
US9808558B2 (en) 2008-11-20 2017-11-07 Allosource Allografts combined with tissue derived stem cells for bone healing
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10335281B2 (en) 2013-02-22 2019-07-02 Allosource Cartilage mosaic compositions and methods
US11229725B2 (en) 2013-03-15 2022-01-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US11452796B2 (en) 2017-06-30 2022-09-27 Allosource Cellular bone grafts, and methods of manufacture and use

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US20050064042A1 (en) * 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7488348B2 (en) * 2003-05-16 2009-02-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US8435551B2 (en) * 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
CA2708147A1 (en) * 2007-12-05 2009-06-18 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
US8685432B2 (en) * 2008-03-25 2014-04-01 University Of Utah Research Foundation Controlled release tissue graft combination biomaterials
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
US9889235B2 (en) 2013-02-05 2018-02-13 University Of Utah Research Foundation Implantable devices for bone or joint defects
ES2895457T3 (en) * 2015-04-27 2022-02-21 Corenman Donald Steven Biological disc graft and procedure to relieve low back and joint pain
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
US3476855A (en) * 1965-02-26 1969-11-04 Leslie L Balassa Sterilizing and enhancing activity of a finely divided cartilage powder
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
US3772432A (en) * 1971-01-11 1973-11-13 Lescarden Ltd Cartilage compositions for dental use
US3867728A (en) * 1971-12-30 1975-02-25 Cutter Lab Prosthesis for spinal repair
US3966908A (en) * 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4172128A (en) * 1975-03-26 1979-10-23 Erhard Thiele Process of degrading and regenerating bone and tooth material and products
US4201845A (en) * 1976-04-12 1980-05-06 Monsanto Company Cell culture reactor
US4400833A (en) * 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4458678A (en) * 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
US4479271A (en) * 1981-10-26 1984-10-30 Zimmer, Inc. Prosthetic device adapted to promote bone/tissue ingrowth
US4501269A (en) * 1981-12-11 1985-02-26 Washington State University Research Foundation, Inc. Process for fusing bone joints
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
US4609551A (en) * 1984-03-20 1986-09-02 Arnold Caplan Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites
US4627853A (en) * 1985-05-29 1986-12-09 American Hospital Supply Corporation Method of producing prostheses for replacement of articular cartilage and prostheses so produced
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4681763A (en) * 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
US4757017A (en) * 1984-09-14 1988-07-12 Mcw Research Foundation, Inc. In vitro cell culture system
US4776173A (en) * 1985-12-20 1988-10-11 Angio-Medical Corporation Method for extracting a substance from animal derived material
US4776853A (en) * 1986-07-28 1988-10-11 Hsc Research Development Corporation Process for preparing biological mammalian implants
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4846835A (en) * 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US4880429A (en) * 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
US4932973A (en) * 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
US4950296A (en) * 1988-04-07 1990-08-21 Mcintyre Jonathan L Bone grafting units
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5002071A (en) * 1987-04-03 1991-03-26 Research Development Foundation Injectable soft tissue augmentation materials from the placenta and their method of manufacture
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5067963A (en) * 1990-08-21 1991-11-26 Washington University Method of making live autogenous skeletal replacement parts
US5092887A (en) * 1991-08-12 1992-03-03 El Gendler Artificial ligament produced from demineralized bone for the replacement and augmentation of ligaments, tendons and other fibrous connective tissue
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5281422A (en) * 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5510395A (en) * 1993-02-10 1996-04-23 Unitika, Ltd. Film forming solution, porous film obtained therefrom and coated material with the porous film
US5516533A (en) * 1992-11-13 1996-05-14 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5518925A (en) * 1995-06-06 1996-05-21 Becton Dickinson Co Culture slide assembly
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US5554389A (en) * 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5755791A (en) * 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US5788625A (en) * 1996-04-05 1998-08-04 Depuy Orthopaedics, Inc. Method of making reconstructive SIS structure for cartilaginous elements in situ
US5881733A (en) * 1996-09-13 1999-03-16 Depuy Orthopaedic Technology, Inc. Technique for osteocartilaginous transplantation in a mammalian joint
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US6056777A (en) * 1998-02-27 2000-05-02 Mcdowell; Charles L. Method and device for regenerating cartilage in articulating
US6146385A (en) * 1997-02-11 2000-11-14 Smith & Nephew, Inc. Repairing cartilage
US6197061B1 (en) * 1999-03-01 2001-03-06 Koichi Masuda In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
US6306177B1 (en) * 1994-05-06 2001-10-23 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6371958B1 (en) * 2000-03-02 2002-04-16 Ethicon, Inc. Scaffold fixation device for use in articular cartilage repair
US20020099448A1 (en) * 1996-08-23 2002-07-25 Michael C. Hiles Multi-formed collagenous biomaterial medical device
US6504079B2 (en) * 1995-06-07 2003-01-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US20030077821A1 (en) * 2001-09-15 2003-04-24 Sah Robert L. Methods to engineer stratified cartilage tissue
US6576265B1 (en) * 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
US6579538B1 (en) * 1999-12-22 2003-06-17 Acell, Inc. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
USRE38522E1 (en) * 1998-02-27 2004-05-25 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
US20040107003A1 (en) * 2001-02-28 2004-06-03 Synthes (Usa) Demineralized bone implants
US20040127987A1 (en) * 2002-06-13 2004-07-01 Evans Douglas G. Devices and methods for treating defects in the tissue of a living being
US6849255B2 (en) * 1998-08-18 2005-02-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for enhancing cartilage repair
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US7087227B2 (en) * 1997-04-04 2006-08-08 Barnes-Jewish Hospital Cartilage composites and methods of use
US20060293757A1 (en) * 2005-06-22 2006-12-28 Mckay William F Osteograft treatment to promote osteoinduction and osteograft incorporation
USRE39587E1 (en) * 1998-02-27 2007-04-24 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
US7273756B2 (en) * 2004-10-01 2007-09-25 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US20080058953A1 (en) * 2006-08-31 2008-03-06 Scarborough Nelson L Demineralized cancellous strip DBM graft
US20080153157A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20080249632A1 (en) * 2007-02-26 2008-10-09 Biomet Sports Medicine, Inc. Stable cartilage defect repair plug
US20080294270A1 (en) * 2007-05-24 2008-11-27 Zimmer Orthobiologics, Inc. Differentially processed tissue and processing methods thereof
US7475257B2 (en) * 2003-09-25 2009-01-06 International Business Machines Corporation System and method for selecting and using a signal processor in a multiprocessor system to operate as a security for encryption/decryption of data
US20090024224A1 (en) * 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
US7548865B2 (en) * 2000-10-20 2009-06-16 Arthrex, Inc. Method of selling procedure specific allografts and associated instrumentation
US20090324722A1 (en) * 2004-09-22 2009-12-31 Elisseeff Jennifer H Cartilage filling device
USRE41286E1 (en) * 1997-08-14 2010-04-27 Zimmer Orthobiologics, Inc. Compositions for regeneration and repair of cartilage lesions
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US7824701B2 (en) * 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7875296B2 (en) * 2003-11-26 2011-01-25 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US20110052705A1 (en) * 2004-03-08 2011-03-03 Malinin Theodore I Cartilage composition and process for producing the cartilage composition
USRE42208E1 (en) * 2003-04-29 2011-03-08 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7901451B2 (en) * 2004-09-24 2011-03-08 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20110070271A1 (en) * 2004-10-12 2011-03-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20110104242A1 (en) * 2007-05-10 2011-05-05 Malinin Theodore I Cartilage material

Family Cites Families (397)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US815416A (en) * 1904-12-05 1906-03-20 Stephen A Garland Elevating-truck.
US4296100A (en) 1980-06-30 1981-10-20 Franco Wayne P Method of treating the heart for myocardial infarction
US4378347A (en) 1980-06-30 1983-03-29 Franco Wayne P Composition for treating the heart for myocardial infarction
US4442655A (en) 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
AT369990B (en) 1981-07-28 1983-02-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US5155214A (en) 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US4600574A (en) 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
CH665348A5 (en) 1985-01-09 1988-05-13 Sulzer Ag IMPLANTS.
CH665770A5 (en) 1985-01-25 1988-06-15 Sulzer Ag PLASTIC BONE IMPLANT.
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA1260391A (en) 1985-03-28 1989-09-26 Karl A. Piez Xenogeneic collagen/mineral preparations in bone repair
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5053049A (en) 1985-05-29 1991-10-01 Baxter International Flexible prostheses of predetermined shapes and process for making same
US5266476A (en) 1985-06-18 1993-11-30 Yeda Research & Development Co., Ltd. Fibrous matrix for in vitro cell cultivation
IL76079A (en) 1985-08-13 1991-03-10 Univ Ramot Collagen implants
US5439818A (en) 1985-09-12 1995-08-08 Scios Nova Inc. DNA encoding human recombinant basic fibroblast growth factor
US5859208A (en) 1988-07-06 1999-01-12 Fiddes; John C. Human basic fibroblast growth factor analog
US5604293A (en) 1985-09-12 1997-02-18 Scios Inc. Recombinant human basic fibroblast growth factor
US4994559A (en) 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
US6005161A (en) 1986-01-28 1999-12-21 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
SU1454423A1 (en) 1986-06-27 1989-01-30 Киевский Медицинский Институт Им.Акад.А.А.Богомольца Method of recovery of articular surface of cystic condyles of the femur in case of rheumatoid arthritis
FI80605C (en) 1986-11-03 1990-07-10 Biocon Oy Bone surgical biocomposite material
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US5306311A (en) 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5007934A (en) 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
US5260420A (en) 1987-07-30 1993-11-09 Centre Regional De Transfusion Sanguine De Lille Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
CH674139A5 (en) 1988-04-21 1990-05-15 Sulzer Ag
US5053050A (en) 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US4837379A (en) 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
US5496722A (en) 1988-06-30 1996-03-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method for producing non-neoplastic, three dimensional, mammalian tissue and cell aggregates under microgravity culture conditions and the products produced therefrom
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
DE3826915A1 (en) 1988-08-09 1990-02-15 Henkel Kgaa NEW MATERIALS FOR BONE REPLACEMENT AND BONE OR PROSTHESIS COMPOSITION
US4971954A (en) 1988-11-23 1990-11-20 University Of Medicine And Dentistry Of New Jersey Collagen-based matrices ribose cross-linked
US4963146A (en) 1989-04-20 1990-10-16 Colla-Tec Incorporated Multi-layered, semi-permeable conduit for nerve regeneration
US5191067A (en) 1989-04-27 1993-03-02 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5576288A (en) 1989-04-27 1996-11-19 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5073373A (en) 1989-09-21 1991-12-17 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5236456A (en) 1989-11-09 1993-08-17 Osteotech, Inc. Osteogenic composition and implant containing same
US5152791A (en) 1989-12-07 1992-10-06 Olympus Optical Co., Ltd. Prosthetic artificial bone having ceramic layers of different porosity
US5067964A (en) 1989-12-13 1991-11-26 Stryker Corporation Articular surface repair
US5118512A (en) 1990-01-23 1992-06-02 Osteotech, Inc. (A Delaware Corp.) Process for cryopreserving biological materials and materials prepared thereby
US5425769A (en) 1990-04-23 1995-06-20 Snyders, Jr.; Robert V. Composition of material for osseous repair
US5080194A (en) * 1990-04-26 1992-01-14 Houston Industries Incorporated Gaff protective cover
FR2664808A1 (en) 1990-07-23 1992-01-24 Gersberg Eduardo System of dental implants
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
DE69111021T2 (en) 1990-10-31 1996-01-04 Gendler El Flexible membrane made from organic bone matrix for repairing and restoring bones.
EP0486862B1 (en) 1990-11-23 1996-05-29 American Cyanamid Company Chimeric fibroblast growth factor
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5853746A (en) 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US5312456A (en) 1991-01-31 1994-05-17 Carnegie Mellon University Micromechanical barb and method for making the same
JP3385040B2 (en) 1991-02-14 2003-03-10 武田薬品工業株式会社 Glial activator and method for producing the same
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
DE4215137A1 (en) 1991-06-04 1992-12-10 Man Ceramics Gmbh IMPLANT FOR SPINE PILLARS
SE9101853D0 (en) 1991-06-17 1991-06-17 Jonas Wadstroem IMPROVED TISSUE ASHESIVE
US6440427B1 (en) 1991-06-17 2002-08-27 Biovitrum Ab Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
DE4120325A1 (en) 1991-06-20 1992-12-24 Merck Patent Gmbh IMPLANT MATERIAL
US5356629A (en) 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
US5329846A (en) 1991-08-12 1994-07-19 Bonutti Peter M Tissue press and system
US6503277B2 (en) 1991-08-12 2003-01-07 Peter M. Bonutti Method of transplanting human body tissue
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5284155A (en) 1991-12-06 1994-02-08 The General Hospital Corporation Cartilage degradation assay system
US5513662A (en) 1991-12-31 1996-05-07 Osteotech, Inc. Preparation of bone for transplantation
US5314476A (en) 1992-02-04 1994-05-24 Osteotech, Inc. Demineralized bone particles and flowable osteogenic composition containing same
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
DE69307299T2 (en) 1992-02-14 1997-04-30 Univ Texas MULTI-PHASE, BIODEGRADABLE IMPLANT / CARRIER AND METHOD FOR THE PRODUCTION THEREOF
WO1993016739A1 (en) 1992-02-19 1993-09-02 Eberlin Jean Luc Collagen- and fibrin adhesive-based graft for osteocartilaginous reconstruction, and preparation method therefor
US5326357A (en) 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
EP0656939B1 (en) 1992-08-07 2004-03-31 TEI Biosciences, Inc. Production of graft tissue from extracellular matrix
US5800537A (en) 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
US5352463A (en) 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
EP0608546A3 (en) 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.
US5380328A (en) 1993-08-09 1995-01-10 Timesh, Inc. Composite perforated implant structures
US5491220A (en) 1993-09-24 1996-02-13 Yeda Research And Development Co., Ltd. Surface loop structural analogues of fibroblast growth factors
US5507813A (en) 1993-12-09 1996-04-16 Osteotech, Inc. Shaped materials derived from elongate bone particles
US5411885A (en) 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
EP0881908B1 (en) 1994-03-08 2004-06-16 Osteosa Inc. Use of fibroblast growth factors to stimulate bone growth
US5656598A (en) 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
CA2185447C (en) 1994-03-14 2009-05-05 Steven Goldstein Treated tissue for implantation and preparation methods
EP0699210A1 (en) 1994-03-18 1996-03-06 Baxter International Inc. Topical fibrinogen complex
US5916265A (en) 1994-03-30 1999-06-29 Hu; Jie Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US7963997B2 (en) 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
IL110367A (en) 1994-07-19 2007-05-15 Colbar Lifescience Ltd Collagen-based matrix
US5516532A (en) 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5632745A (en) 1995-02-07 1997-05-27 R&D Biologicals, Inc. Surgical implantation of cartilage repair unit
US5769899A (en) 1994-08-12 1998-06-23 Matrix Biotechnologies, Inc. Cartilage repair unit
US5707962A (en) 1994-09-28 1998-01-13 Gensci Regeneration Sciences Inc. Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
TW369414B (en) 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US20010011131A1 (en) 1997-07-28 2001-08-02 Luyten Frank P. DNA molecules encoding cartilage-derived morphogenetic proteins
US5709934A (en) 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US6599515B1 (en) 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
WO1996022115A1 (en) 1995-01-16 1996-07-25 Baxter International Inc. Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions
US5749874A (en) 1995-02-07 1998-05-12 Matrix Biotechnologies, Inc. Cartilage repair unit and method of assembling same
US6080194A (en) 1995-02-10 2000-06-27 The Hospital For Joint Disease Orthopaedic Institute Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US5713374A (en) 1995-02-10 1998-02-03 The Hospital For Joint Diseases Orthopaedic Institute Fixation method for the attachment of wound repair materials to cartilage defects
US20030039695A1 (en) 2001-08-10 2003-02-27 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen carrier of therapeutic genetic material, and method
US7141072B2 (en) 1998-10-05 2006-11-28 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering
GB9721585D0 (en) 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
US5782835A (en) 1995-03-07 1998-07-21 Innovasive Devices, Inc. Apparatus and methods for articular cartilage defect repair
AU5564996A (en) 1995-04-19 1996-11-07 St. Jude Medical Inc. Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5904716A (en) 1995-04-26 1999-05-18 Gendler; El Method for reconstituting cartilage tissue using demineralized bone and product thereof
US6060640A (en) 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
US6039762A (en) 1995-06-07 2000-03-21 Sdgi Holdings, Inc. Reinforced bone graft substitutes
US5782915A (en) 1995-09-15 1998-07-21 Stone; Kevin R. Articular cartilage heterografts
WO1997013839A1 (en) 1995-10-06 1997-04-17 Microcloning Cccd Ab Compact cell culture slide
US5716413A (en) 1995-10-11 1998-02-10 Osteobiologics, Inc. Moldable, hand-shapable biodegradable implant material
US5989289A (en) 1995-10-16 1999-11-23 Sdgi Holdings, Inc. Bone grafts
US20020111695A1 (en) 1995-11-06 2002-08-15 Mount Sinai Hospital Corporation Reconstituted mineralized cartilage tissue
IL116477A (en) 1995-12-21 2000-02-29 Hadasit Med Res Service Bone graft substitute and process for producing same
US5814084A (en) 1996-01-16 1998-09-29 University Of Florida Tissue Bank, Inc. Diaphysial cortical dowel
US5964724A (en) 1996-01-31 1999-10-12 Medtronic Electromedics, Inc. Apparatus and method for blood separation
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US6352558B1 (en) 1996-02-22 2002-03-05 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method for promoting regeneration of surface cartilage in a damage joint
US6221854B1 (en) 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US5700774A (en) 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
AU731468B2 (en) 1996-04-19 2001-03-29 Mesoblast International Sarl Regeneration and augmentation of bone using mesenchymal stem cells
ES2210526T3 (en) 1996-06-04 2004-07-01 Centerpulse Biologics Inc. CARTILAGO PRODUCTION PROCEDURE.
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5759190A (en) 1996-08-30 1998-06-02 Vts Holdings Limited Method and kit for autologous transplantation
US6569172B2 (en) 1996-08-30 2003-05-27 Verigen Transplantation Service International (Vtsi) Method, instruments, and kit for autologous transplantation
US5989269A (en) 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
US6189537B1 (en) 1996-09-06 2001-02-20 Lifenet Process for producing osteoinductive bone, and osteoinductive bone produced thereby
US5964805A (en) 1997-02-12 1999-10-12 Stone; Kevin R. Method and paste for articular cartilage transplantation
JP2001501934A (en) 1996-09-30 2001-02-13 チルドレンズ メディカル センター コーポレーション Methods and compositions for programming an organic matrix to remodel to a target tissue
US6165487A (en) 1996-09-30 2000-12-26 Children's Medical Center Corporation Methods and compositions for programming an organic matrix for remodeling into a target tissue
PT931148E (en) 1996-10-16 2006-06-30 Zymogenetics Inc HOMOLOGES OF THE FIBROBLASTIC GROWTH FACTOR
EP1438935A3 (en) 1996-10-23 2005-03-02 SDGI Holdings, Inc. Spinal spacer
US5974663A (en) 1996-10-25 1999-11-02 Honda Giken Kogya Kabushiki Kaisha Method of manufacturing connecting rod
CA2267449C (en) 1996-11-05 2008-10-14 Purdue Research Foundation Myocardial graft constructs
DE19647853A1 (en) 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Compounds with improved cartilage and / or bone inducing activity
US7468075B2 (en) 2001-05-25 2008-12-23 Conformis, Inc. Methods and compositions for articular repair
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
EP0957943B2 (en) 1997-02-07 2008-11-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US5866415A (en) 1997-03-25 1999-02-02 Villeneuve; Peter E. Materials for healing cartilage and bone defects
US6001352A (en) 1997-03-31 1999-12-14 Osteobiologics, Inc. Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
CA2307954C (en) 1997-04-03 2010-07-13 California Institute Of Technology Enzyme-medicated modification of fibrin for tissue engineering
DE69840171D1 (en) 1997-05-30 2008-12-11 Osteobiologics Inc FIBER REINFORCED, POROUS, BIODEGRADABLE IMPLANT DEVICE
US7524335B2 (en) 1997-05-30 2009-04-28 Smith & Nephew, Inc. Fiber-reinforced, porous, biodegradable implant device
US5972368A (en) 1997-06-11 1999-10-26 Sdgi Holdings, Inc. Bone graft composites and spacers
AU752800B2 (en) 1997-07-03 2002-10-03 Depuy Acromed, Inc. Cross-linked polysaccharide drug carrier
US5910315A (en) 1997-07-18 1999-06-08 Stevenson; Sharon Allograft tissue material for filling spinal fusion cages or related surgical spaces
US6471993B1 (en) 1997-08-01 2002-10-29 Massachusetts Institute Of Technology Three-dimensional polymer matrices
US6090996A (en) 1997-08-04 2000-07-18 Collagen Matrix, Inc. Implant matrix
US6110209A (en) 1997-08-07 2000-08-29 Stone; Kevin R. Method and paste for articular cartilage transplantation
US6511958B1 (en) 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US20010031254A1 (en) 1998-11-13 2001-10-18 Bianchi John R. Assembled implant
US7048762B1 (en) 1997-08-27 2006-05-23 Regeneration Technologies, Inc. Elongated cortical bone implant
US20020138143A1 (en) 1997-08-27 2002-09-26 Grooms Jamie M. Cortical bone cervical Smith-Robinson fusion implant
WO1999009914A1 (en) 1997-08-27 1999-03-04 University Of Florida Tissue Bank, Inc. Cortical bone cervical smith-robinson fusion implant
US6309659B1 (en) 1997-09-02 2001-10-30 Gensci Orthobiologics, Inc. Reverse phase connective tissue repair composition
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
AT407117B (en) 1997-09-19 2000-12-27 Immuno Ag FIBRINE SPONGE
US5998170A (en) 1997-10-03 1999-12-07 Amgen Inc. Polynucleotides encoding hepatocyte-specific members of the FGF family
EP1027001A1 (en) 1997-10-27 2000-08-16 Sulzer Orthopädie AG Method and instruments for repairing endochondral and osteochondral defects
US6090998A (en) 1997-10-27 2000-07-18 University Of Florida Segmentally demineralized bone implant
US6652592B1 (en) 1997-10-27 2003-11-25 Regeneration Technologies, Inc. Segmentally demineralized bone implant
US20030099620A1 (en) 1997-10-30 2003-05-29 The General Hospital Corporation Bonding of cartilaginous matrices using isolated chondrocytes
WO1999022747A1 (en) 1997-10-30 1999-05-14 The General Hospital Corporation Bonding of cartilaginous matrices using isolated chondrocytes
US6274663B1 (en) 1997-10-30 2001-08-14 Showa Denko K.K. Compound resin composition
US6197586B1 (en) 1997-12-12 2001-03-06 The Regents Of The University Of California Chondrocyte-like cells useful for tissue engineering and methods
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
US5899939A (en) 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
US6712851B1 (en) 1998-01-23 2004-03-30 Macropore Biosurgery, Inc. Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration
DE19803673A1 (en) 1998-01-30 1999-08-05 Norbert M Dr Meenen Biohybrid joint replacement
US6123731A (en) 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US6437018B1 (en) 1998-02-27 2002-08-20 Musculoskeletal Transplant Foundation Malleable paste with high molecular weight buffered carrier for filling bone defects
US6911212B2 (en) 1998-02-27 2005-06-28 Musculoskeletal Transplant Foundation Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
US7019192B2 (en) 1998-02-27 2006-03-28 Musculoskeletal Transplant Foundation Composition for filling bone defects
US6458375B1 (en) 1998-02-27 2002-10-01 Musculoskeletal Transplant Foundation Malleable paste with allograft bone reinforcement for filling bone defects
US6030635A (en) 1998-02-27 2000-02-29 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
US7045141B2 (en) 1998-02-27 2006-05-16 Musculoskeletal Transplant Foundation Allograft bone composition having a gelatin binder
US6143293A (en) 1998-03-26 2000-11-07 Carnegie Mellon Assembled scaffolds for three dimensional cell culturing and tissue generation
US20040044408A1 (en) 1998-04-08 2004-03-04 Hungerford David S. Cell-culture and polymer constructs
WO1999056797A1 (en) 1998-05-01 1999-11-11 Zymogenetics, Inc. Fully recombinant tissue sealant compositions
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US20080077251A1 (en) 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US6734018B2 (en) 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6293970B1 (en) 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
DE69911609T2 (en) 1998-07-13 2004-07-01 University Of Southern California, Los Angeles PROCESS FOR ACCELERATING THE GROWTH AND HEALING OF BONES AND CARTILES
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6270528B1 (en) 1998-08-06 2001-08-07 Sdgi Holdings, Inc. Composited intervertebral bone spacers
TR200100482T2 (en) 1998-08-14 2001-06-21 Verigen Transplantation Service International(Vtsi)Ag Methods for chondrocyte cell transplantation; instruments and items
US6530956B1 (en) 1998-09-10 2003-03-11 Kevin A. Mansmann Resorbable scaffolds to promote cartilage regeneration
CA2344399A1 (en) 1998-09-18 2000-03-30 Massachusetts Institute Of Technology Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
AU768641B2 (en) 1998-10-12 2003-12-18 Massachusetts Institute Of Technology Composites for tissue regeneration and methods of manufacture thereof
AU1116400A (en) 1998-10-14 2000-05-01 Orquest, Inc. A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
US6174311B1 (en) 1998-10-28 2001-01-16 Sdgi Holdings, Inc. Interbody fusion grafts and instrumentation
DE19851334C2 (en) 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible fibrin-based wound dressing and process for its manufacture
US6497726B1 (en) 2000-01-11 2002-12-24 Regeneration Technologies, Inc. Materials and methods for improved bone tendon bone transplantation
US6761887B1 (en) 1998-11-16 2004-07-13 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
US6165486A (en) 1998-11-19 2000-12-26 Carnegie Mellon University Biocompatible compositions and methods of using same
US6025538A (en) 1998-11-20 2000-02-15 Musculoskeletal Transplant Foundation Compound bone structure fabricated from allograft tissue
US6306174B1 (en) 1998-12-18 2001-10-23 Benoist Girard Sas Femoral component
US20020165611A1 (en) 1998-12-22 2002-11-07 Robert-Jan Enzerink Graft material convenience package
US6200347B1 (en) 1999-01-05 2001-03-13 Lifenet Composite bone graft, method of making and using same
US6547823B2 (en) 1999-01-22 2003-04-15 Osteotech, Inc. Intervertebral implant
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
ATE253385T1 (en) 1999-02-04 2003-11-15 Sdgi Holdings Inc HIGHLY MINERALIZED OSTEOGENIC SPONGE COMPOSITIONS AND THEIR USE
US6267786B1 (en) 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
AU2984700A (en) 1999-02-12 2000-08-29 Collagenesis, Inc. Injectable collagen-based delivery system for bone morphogenic proteins
US6696073B2 (en) 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
US6294187B1 (en) 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US6662805B2 (en) 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
EP1093390B1 (en) 1999-04-12 2013-05-08 Harvest Technologies Corporation Method and apparatus for producing platelet rich plasma and/or platelet concentrate
US7338524B2 (en) 1999-05-10 2008-03-04 Fell Barry M Surgically implantable knee prosthesis
US7297161B2 (en) 1999-05-10 2007-11-20 Fell Barry M Surgically implantable knee prosthesis
US6251143B1 (en) 1999-06-04 2001-06-26 Depuy Orthopaedics, Inc. Cartilage repair unit
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6652872B2 (en) 1999-07-06 2003-11-25 Ramat At Tel Aviv University Ltd. Scaffold formed of tissue treated to eliminate cellular and cytosolic elements
US7056885B1 (en) 1999-07-27 2006-06-06 Curagen Corporation Fibroblast growth factor and nucleic acids encoding same
US7078232B2 (en) 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US7687462B2 (en) 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
WO2001038357A2 (en) 1999-11-22 2001-05-31 Millennium Pharmaceuticals, Inc. Jaffa, a novel fibroblast growth factor family member and uses therefor
DE19957388A1 (en) 1999-11-24 2001-06-13 Michael Sittinger Chondroinductive and implantable substrates for cartilage healing and protection
CA2393200C (en) 1999-12-02 2011-07-12 Zymogenetics, Inc. Methods for targeting cells that express fibroblast growth receptor-3 or-2
EP1233707B1 (en) 1999-12-03 2007-08-08 The University Of Leeds Repair of damaged tissue
US6858042B2 (en) 1999-12-15 2005-02-22 Zimmer Orthobiologics, Inc. Preparation for repairing cartilage defects or cartilage/bone defects in human or animal joints
US6623963B1 (en) 1999-12-20 2003-09-23 Verigen Ag Cellular matrix
DE69933057T2 (en) 1999-12-22 2007-03-15 Ortho-Mcneil Pharmaceutical, Inc. ANALOGS OF THE HUMAN BASIC FIBROBLAST GROWTH FACTOR
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
WO2001049333A2 (en) 1999-12-30 2001-07-12 Osteotech, Inc. Methods for manufacturing skeletal implants
US6379385B1 (en) 2000-01-06 2002-04-30 Tutogen Medical Gmbh Implant of bone matter
US6893462B2 (en) 2000-01-11 2005-05-17 Regeneration Technologies, Inc. Soft and calcified tissue implants
WO2001078798A1 (en) 2000-02-10 2001-10-25 Regeneration Technologies, Inc. Assembled implant
US7182781B1 (en) 2000-03-02 2007-02-27 Regeneration Technologies, Inc. Cervical tapered dowel
US6591581B2 (en) 2000-03-08 2003-07-15 Arthrex, Inc. Method for preparing and inserting round, size specific osteochondral cores in the knee
US6626945B2 (en) 2000-03-14 2003-09-30 Chondrosite, Llc Cartilage repair plug
AR027685A1 (en) 2000-03-22 2003-04-09 Synthes Ag METHOD AND METHOD FOR CARRYING OUT
DE60120372T2 (en) 2000-03-24 2007-07-05 Genentech Inc., San Francisco USE OF INSULIN FOR THE TREATMENT OF CORTICAL DISEASES
EP1142596A1 (en) 2000-04-03 2001-10-10 Universiteit Gent Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
US6932977B2 (en) 2000-04-14 2005-08-23 Depuy Spine, Inc. Method of inducing or enhancing chondrogenesis with extracellular matrix containing BMP-4
US6520964B2 (en) 2000-05-01 2003-02-18 Std Manufacturing, Inc. System and method for joint resurface repair
US7108721B2 (en) 2000-05-11 2006-09-19 Massachusetts Institute Of Technology Tissue regrafting
CA2409479A1 (en) 2000-05-12 2001-11-22 Osteotech, Inc. Osteoimplant and method for making same
US6488033B1 (en) 2000-05-15 2002-12-03 Cryolife, Inc. Osteochondral transplant techniques
US6686184B1 (en) 2000-05-25 2004-02-03 President And Fellows Of Harvard College Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks
JP2004501719A (en) 2000-07-03 2004-01-22 オステオテック インコーポレーテッド Osteogenic implants derived from bone
US7018416B2 (en) 2000-07-06 2006-03-28 Zimmer Spine, Inc. Bone implants and methods
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
DK177997B1 (en) 2000-07-19 2015-02-23 Ed Geistlich Söhne Ag Für Chemische Ind Bone material and collagen combination for healing of damaged joints
WO2002007748A2 (en) 2000-07-20 2002-01-31 The Board Of Regents, The University Of Texas System Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
US6440141B1 (en) 2000-07-24 2002-08-27 Oratec Interventions, Inc. Method and apparatus for treating osteochondral pathologies
AU2001275746B2 (en) 2000-07-29 2007-04-26 Smith & Nephew Plc Tissue implant for cartilage repair
US8366787B2 (en) 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
DE10042484A1 (en) 2000-08-29 2002-03-28 Merck Patent Gmbh Preparing human cartilage implants, useful for repairing damaged joints, comprises culturing autologous chondrocytes in alginate gel at reduced oxygen partial pressure
AU2001287023A1 (en) 2000-09-01 2002-03-13 Virginia Commonwealth University Intellectual Property Foundation Plasma-derived-fibrin-based matrices and tissue
IL138529A0 (en) 2000-09-18 2003-09-17 Yeda Res & Dev High level expression of heterologous proteins
US6432436B1 (en) 2000-10-03 2002-08-13 Musculoskeletal Transplant Foundation Partially demineralized cortical bone constructs
IL139380A0 (en) 2000-10-31 2001-11-25 Prochon Biotech Ltd Active variants of fibroblast growth factor
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
WO2002053193A2 (en) 2001-01-02 2002-07-11 The Charles Stark Draper Laboratory, Inc. Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
US6838440B2 (en) 2001-01-24 2005-01-04 Collagen Nutraceuticals, Inc. Kolla2-desiccated avian sternal cartilage powder
NZ527916A (en) 2001-01-30 2006-10-27 Orthogene Inc Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
WO2002064181A1 (en) 2001-02-14 2002-08-22 Osteotech, Inc. Implant derived from bone
WO2002098332A1 (en) 2001-02-16 2002-12-12 Sulzer Spine-Tech Inc. Bone implants and methods
US20030050709A1 (en) 2001-02-23 2003-03-13 Ulrich Noth Trabecular bone-derived human mesenchymal stem cells
US6743232B2 (en) 2001-02-26 2004-06-01 David W. Overaker Tissue scaffold anchor for cartilage repair
US6575986B2 (en) 2001-02-26 2003-06-10 Ethicon, Inc. Scaffold fixation device for use in articular cartilage repair
IL141813A (en) 2001-03-05 2010-04-15 Hadasit Med Res Service Mixture comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the preparation of compositions for the treatment of hematopoietic dusirders
US6995013B2 (en) 2002-07-08 2006-02-07 Biomed Solutions, Llc Cell-scaffold composition containing five layers
US7252982B2 (en) 2001-03-15 2007-08-07 Massachusetts Institute Of Technology Tissue engineering enhanced by the transfer of a growth factor gene
US20040151705A1 (en) 2002-03-22 2004-08-05 Shuichi Mizuno Neo-cartilage constructs and a method for preparation thereof
EP2522304B1 (en) 2001-03-23 2014-01-08 Histogenics Corporation Composition and methods for the production of biological tissues and tissue constructs
US20030008820A1 (en) 2001-03-27 2003-01-09 Massachusetts Institute Of Technology Methods and products related to FGF dimerization
ES2274044T3 (en) 2001-05-21 2007-05-16 Omrix Biopharmaceuticals S.A. DISPOSAL OF PLASMINE (PLASMINOGEN) OF PROTEIN SOLUTIONS.
AU2002310193B8 (en) 2001-05-25 2007-05-17 Conformis, Inc. Methods and compositions for articular resurfacing
US6626950B2 (en) 2001-06-28 2003-09-30 Ethicon, Inc. Composite scaffold with post anchor for the repair and regeneration of tissue
EP1416879A4 (en) 2001-07-16 2007-04-25 Depuy Products Inc Unitary surgical device and method
EP1416888A4 (en) 2001-07-16 2007-04-25 Depuy Products Inc Meniscus regeneration device and method
US7361195B2 (en) 2001-07-16 2008-04-22 Depuy Products, Inc. Cartilage repair apparatus and method
US7819918B2 (en) 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
AU2002322567B2 (en) 2001-07-16 2007-09-06 Depuy Products, Inc. Devices form naturally occurring biologically derived
WO2003007786A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Porous delivery scaffold and method
WO2003007787A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Cartilage repair and regeneration device and method
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
US7914808B2 (en) 2001-07-16 2011-03-29 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
IL144446A0 (en) 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
AU2002355844A1 (en) 2001-08-01 2003-02-17 New York University Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis
US8178123B2 (en) 2001-08-29 2012-05-15 Femina Pharma Incorporated Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
US7132110B2 (en) 2001-08-30 2006-11-07 Isotis Orthobiologics, Inc. Tissue repair compositions and methods for their manufacture and use
US6855167B2 (en) 2001-12-05 2005-02-15 Osteotech, Inc. Spinal intervertebral implant, interconnections for such implant and processes for making
US7252987B2 (en) 2001-12-06 2007-08-07 Islet Technology, Inc. System for analysis and selection of encapsulated cellular materials
US6852331B2 (en) 2002-02-11 2005-02-08 Taipei Biotechnology Ltd., Inc. Fabrication of a cartilage implant
US6890354B2 (en) 2002-03-08 2005-05-10 Musculoskeletal Transplant Foundation Bone-tendon-bone assembly with allograft bone block and method for inserting same
US20030175410A1 (en) 2002-03-18 2003-09-18 Campbell Phil G. Method and apparatus for preparing biomimetic scaffold
US7468192B2 (en) 2002-03-22 2008-12-23 Histogenics Corporation Method for repair of cartilage lesions
US7537780B2 (en) * 2002-03-22 2009-05-26 Histogenics Corporation Method for preparing and implanting a cartilage construct to treat cartilage lesions
NL1020426C2 (en) 2002-04-18 2003-10-21 Tno Modification of the properties of a fibrin matrix with respect to cell growth and ingrowth.
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
WO2003094987A1 (en) 2002-05-13 2003-11-20 Toshiba Ceramics Co.,Ltd Member for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and aritficial cartilage for transplantation
US7931687B2 (en) 2002-05-13 2011-04-26 Articular Engineering, Llc Tissue engineered osteochondral implant
US7338492B2 (en) 2002-05-15 2008-03-04 Linvatec Corporation Cross-pin graft fixation, instruments, and methods
US6989034B2 (en) 2002-05-31 2006-01-24 Ethicon, Inc. Attachment of absorbable tissue scaffolds to fixation devices
US7291179B2 (en) 2002-06-24 2007-11-06 Wright Medical Technology, Inc. Bone graft substitute composition
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US20040166169A1 (en) 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
US7264634B2 (en) 2002-09-20 2007-09-04 Arthrex, Inc. Method and instrumentation for osteochondral repair using preformed implants
US20040062753A1 (en) 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells
US7323011B2 (en) * 2002-10-18 2008-01-29 Musculoskeletal Transplant Foundation Cortical and cancellous allograft cervical fusion block
US6761739B2 (en) 2002-11-25 2004-07-13 Musculoskeletal Transplant Foundation Cortical and cancellous allograft spacer
AT500418B1 (en) 2002-12-05 2009-12-15 Winkler Heinz Dr CULTIVATED CELLULAR CELLS CONTAINING THE IMPLANT AND METHOD FOR THE PRODUCTION THEREOF
EP1592373B1 (en) 2003-01-30 2013-04-24 ProChon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7985414B2 (en) 2003-02-04 2011-07-26 Warsaw Orthopedic, Inc. Polyurethanes for osteoimplants
EP1444995A1 (en) 2003-02-06 2004-08-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) FGF-2 derived proteins for the preparation of biomaterials or medical devices such as stents
WO2004075940A1 (en) 2003-02-26 2004-09-10 Zimmer Orthobiologics, Inc. Preparation for repairing cartilage tissue, especially articular cartilage defects
US7642092B2 (en) 2003-03-03 2010-01-05 Technion Research & Development Foundation Ltd. Cultured cartilage/bone cells/tissue, method of generating same and uses thereof
US7125423B2 (en) 2003-03-31 2006-10-24 Depuy Products, Inc. Intercalary prosthesis, kit and method
US20050222687A1 (en) 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US20050064042A1 (en) 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
US7488348B2 (en) 2003-05-16 2009-02-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7537617B2 (en) 2003-06-05 2009-05-26 Warsaw Orthopedic, Inc. Bone strip implants and method of making same
US20070067032A1 (en) 2003-06-27 2007-03-22 Felt Jeffrey C Meniscus preserving implant method and apparatus
ATE528026T1 (en) 2003-07-31 2011-10-15 Yukihide Iwamoto METHOD FOR PRODUCING AN ARTIFICIAL JOINT
CA2533124C (en) 2003-08-12 2014-01-28 Tigenix N.V. Use of cxcl6 chemokine in the prevention or repair of cartilage defects
JP2007503222A (en) 2003-08-20 2007-02-22 ヒストジェニックス コーポレイション Non-cellular cartilage or non-cellular matrix embedded in a lesion site of osteochondral, protected by a biodegradable polymer modified to have an extended polymerization time, its preparation and use
US7217294B2 (en) 2003-08-20 2007-05-15 Histogenics Corp. Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof
US7226482B2 (en) 2003-09-02 2007-06-05 Synthes (U.S.A.) Multipiece allograft implant
AU2004273794A1 (en) 2003-09-05 2005-03-31 Norian Corporation Bone cement compositions having fiber-reinforcement and/or increased flowability
US7763459B2 (en) 2003-10-02 2010-07-27 Depuy Spine, Inc. Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
US20050074476A1 (en) 2003-10-03 2005-04-07 El Gendler Cartilidge and bone induction by artificially perforated organic bone matrix augmented by undifferentiated cells suspended in bone gel
EP1526760A1 (en) 2003-10-21 2005-04-27 IEE INTERNATIONAL ELECTRONICS &amp; ENGINEERING S.A. Multiple electroluminescent lamp driver
GB0325141D0 (en) 2003-10-28 2003-12-03 Xiros Plc Repair of damaged tissue on a bone site
US7157428B2 (en) 2003-11-26 2007-01-02 Histogenics, Corp. Method for treatment and repair of meniscal injuries
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US7666230B2 (en) 2003-12-08 2010-02-23 Depuy Products, Inc. Implant device for cartilage regeneration in load bearing articulation regions
ATE515245T1 (en) 2003-12-11 2011-07-15 Isto Technologies Inc PARTICLE CARTILAGE SYSTEM
US20050209705A1 (en) 2004-03-09 2005-09-22 Niederauer Gabriele G Implant scaffold combined with autologous or allogenic tissue
US20070185585A1 (en) 2004-03-09 2007-08-09 Brat Bracy Implant Scaffold Combined With Autologous Tissue, Allogenic Tissue, Cultured Tissue, or combinations Thereof
US7531518B2 (en) 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
ES2245879B1 (en) 2004-05-21 2006-12-16 Universidad De Malaga COMPOSITION FOR OSEA OR CARTILAGINOUS REPAIR.
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US8043315B2 (en) 2004-09-23 2011-10-25 Arthrex, Inc. Osteochondral repair using plug fashioned from partial distal allograft femur or condyle
US20060111778A1 (en) 2004-10-29 2006-05-25 Michalow Alexander E Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway
EP1835867A2 (en) 2004-11-30 2007-09-26 Osteobiologics, Inc. Implants and delivery system for treating defects in articulating surfaces
SE0403020D0 (en) 2004-12-13 2004-12-13 Rickard Braanemark Implant
EP1883398A4 (en) 2005-02-01 2012-06-06 Osteobiologics Inc Method and device for selective addition of a bioactive agent to a multi-phase implant
US7621963B2 (en) 2005-04-13 2009-11-24 Ebi, Llc Composite bone graft material
US7291169B2 (en) 2005-04-15 2007-11-06 Zimmer Technology, Inc. Cartilage implant
US7879103B2 (en) 2005-04-15 2011-02-01 Musculoskeletal Transplant Foundation Vertebral disc repair
US8506646B2 (en) 2005-04-29 2013-08-13 Warsaw Orthopedic, Inc. Multi-purpose medical implant devices
US20060247790A1 (en) 2005-04-30 2006-11-02 Mckay William F Shaped osteochondral grafts and methods of using same
US20060251631A1 (en) 2005-05-05 2006-11-09 Isto Technologies, Inc. Treatment of joint disease, methods and apparatuses therefor
WO2007011610A2 (en) 2005-07-18 2007-01-25 Acologix, Inc. Protein formulation for promoting hard tissue formation
US20070026030A1 (en) 2005-07-27 2007-02-01 Berkeley Advanced Biomaterials, Inc. Method of preparing rheological materials for bone and cartilage repair
US20070029517A1 (en) * 2005-08-04 2007-02-08 Gemco Valve Company Spherical disc valve configured for gravity fed powders
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US9132208B2 (en) 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
US8029575B2 (en) 2005-10-25 2011-10-04 Globus Medical, Inc. Porous and nonporous materials for tissue grafting and repair
US7371260B2 (en) 2005-10-26 2008-05-13 Biomet Sports Medicine, Inc. Method and instrumentation for the preparation and transplantation of osteochondral allografts
US8403985B2 (en) 2005-11-02 2013-03-26 Zimmer, Inc. Joint spacer implant
TWI274591B (en) 2005-11-07 2007-03-01 Univ Tsinghua Composite scaffold for remedying articular cartilage tissue and preparation thereof
CN101384230A (en) 2005-11-21 2009-03-11 福特真公司 Devices and methods for treating facet joints, uncovertebral joints, costovertebral joints and other joints
US20070129630A1 (en) 2005-12-07 2007-06-07 Shimko Daniel A Imaging method, device and system
WO2007067637A2 (en) 2005-12-07 2007-06-14 Isto Technologies, Inc. Cartilage repair methods
TWI316860B (en) 2005-12-29 2009-11-11 Ind Tech Res Inst Multi-layered matrix, method of tissue repair using the same and multi-layered implant prepared thereof
CA2636957A1 (en) 2006-01-12 2007-07-19 Histogenics Corporation Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries
US7833269B2 (en) 2006-01-25 2010-11-16 Warsaw Orthopedic, Inc Osteochondral implant procedure
US20070179607A1 (en) 2006-01-31 2007-08-02 Zimmer Technology, Inc. Cartilage resurfacing implant
DE102006006904A1 (en) 2006-02-09 2007-08-23 Universität Rostock New haemostatic agents and adhesives for medical applications
US20070276506A1 (en) 2006-05-25 2007-11-29 Biomet Manufacturing Corp. Demineralized osteochondral plug
CA2658934A1 (en) 2006-07-25 2008-01-31 Musculoskeletal Transplant Foundation Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
CN101332314B (en) 2008-07-22 2012-11-14 广东冠昊生物科技股份有限公司 Biotype articular cartilage repair piece
US20080039954A1 (en) 2006-08-08 2008-02-14 Howmedica Osteonics Corp. Expandable cartilage implant
US8449622B2 (en) 2006-09-11 2013-05-28 Warsaw Orthopedic, Inc. Multi-phase osteochondral implantable device
US8962556B2 (en) 2006-09-28 2015-02-24 Prochon Biotech Ltd. FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof
GB0623065D0 (en) 2006-11-18 2006-12-27 Smith & Nephew Annular ring
US20080125863A1 (en) 2006-11-28 2008-05-29 Mckay William F Implant designs and methods of improving cartilage repair
US20080138414A1 (en) 2006-12-08 2008-06-12 Smith & Nephew, Inc. Methods of Regenerating Cartilage
US20080154372A1 (en) 2006-12-21 2008-06-26 Peckham Steven M Osteochondral implant using a growth factor concentration gradient for repair of bone and cartilage tissue
US8574825B2 (en) 2007-06-01 2013-11-05 Bacterin International, Inc. Process for demineralization of bone matrix with preservation of natural growth factors
US8685099B2 (en) 2007-08-14 2014-04-01 Warsaw Orthopedic, Inc. Multiple component osteoimplant
US20090069904A1 (en) 2007-09-12 2009-03-12 Applied Medical Research Biomaterial including micropores
US8641774B2 (en) 2007-09-14 2014-02-04 The Curators Of The University Of Missouri Synthetic osteochondral composite and method of fabrication thereof
ES2446544T3 (en) 2007-10-19 2014-03-10 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
US8961571B2 (en) 2007-11-19 2015-02-24 David Lee Method and apparatus for spinal facet joint fusion using irregularly shaped cortical bone implants
CA2708147A1 (en) 2007-12-05 2009-06-18 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
JP2009291304A (en) 2008-06-03 2009-12-17 Gc Corp Bone graft substitute
US20090312842A1 (en) 2008-06-16 2009-12-17 Predrag Bursac Assembled Cartilage Repair Graft
EP2339990A4 (en) 2008-07-06 2013-01-23 Univ Missouri Osteochondral implants, arthroplasty methods, devices, and systems

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
US3476855A (en) * 1965-02-26 1969-11-04 Leslie L Balassa Sterilizing and enhancing activity of a finely divided cartilage powder
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
US3772432A (en) * 1971-01-11 1973-11-13 Lescarden Ltd Cartilage compositions for dental use
US3867728A (en) * 1971-12-30 1975-02-25 Cutter Lab Prosthesis for spinal repair
US3966908A (en) * 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4172128A (en) * 1975-03-26 1979-10-23 Erhard Thiele Process of degrading and regenerating bone and tooth material and products
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4201845A (en) * 1976-04-12 1980-05-06 Monsanto Company Cell culture reactor
US4400833A (en) * 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4479271A (en) * 1981-10-26 1984-10-30 Zimmer, Inc. Prosthetic device adapted to promote bone/tissue ingrowth
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
US4458678A (en) * 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
US4501269A (en) * 1981-12-11 1985-02-26 Washington State University Research Foundation, Inc. Process for fusing bone joints
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4932973A (en) * 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
US4609551A (en) * 1984-03-20 1986-09-02 Arnold Caplan Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites
US4757017A (en) * 1984-09-14 1988-07-12 Mcw Research Foundation, Inc. In vitro cell culture system
US4627853A (en) * 1985-05-29 1986-12-09 American Hospital Supply Corporation Method of producing prostheses for replacement of articular cartilage and prostheses so produced
US4681763A (en) * 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4776173A (en) * 1985-12-20 1988-10-11 Angio-Medical Corporation Method for extracting a substance from animal derived material
US4776853A (en) * 1986-07-28 1988-10-11 Hsc Research Development Corporation Process for preparing biological mammalian implants
US5002071A (en) * 1987-04-03 1991-03-26 Research Development Foundation Injectable soft tissue augmentation materials from the placenta and their method of manufacture
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4846835A (en) * 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US4880429A (en) * 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US4950296A (en) * 1988-04-07 1990-08-21 Mcintyre Jonathan L Bone grafting units
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5067963A (en) * 1990-08-21 1991-11-26 Washington University Method of making live autogenous skeletal replacement parts
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5092887A (en) * 1991-08-12 1992-03-03 El Gendler Artificial ligament produced from demineralized bone for the replacement and augmentation of ligaments, tendons and other fibrous connective tissue
US5281422A (en) * 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5372821A (en) * 1991-09-24 1994-12-13 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5445833A (en) * 1991-09-24 1995-08-29 Purdue Research Foundation Tendon or ligament graft for promoting autogenous tissue growth
US5516533A (en) * 1992-11-13 1996-05-14 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5510395A (en) * 1993-02-10 1996-04-23 Unitika, Ltd. Film forming solution, porous film obtained therefrom and coated material with the porous film
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US5736132A (en) * 1993-06-03 1998-04-07 Orthogene, Inc. Method of promoting adhesion between tissue surfaces
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6306177B1 (en) * 1994-05-06 2001-10-23 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5554389A (en) * 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5518925A (en) * 1995-06-06 1996-05-21 Becton Dickinson Co Culture slide assembly
US6504079B2 (en) * 1995-06-07 2003-01-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US6176880B1 (en) * 1996-04-05 2001-01-23 Depuy Orthopaedics, Inc. Tissue graft construct for replacement of cartilaginous structures
US5788625A (en) * 1996-04-05 1998-08-04 Depuy Orthopaedics, Inc. Method of making reconstructive SIS structure for cartilaginous elements in situ
US5755791A (en) * 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US5922028A (en) * 1996-04-05 1999-07-13 Depuy Orthopaedics, Inc. Multi-layered SIS tissue graft construct for replacement of cartilaginous elements in situ
US20020099448A1 (en) * 1996-08-23 2002-07-25 Michael C. Hiles Multi-formed collagenous biomaterial medical device
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US5881733A (en) * 1996-09-13 1999-03-16 Depuy Orthopaedic Technology, Inc. Technique for osteocartilaginous transplantation in a mammalian joint
US6146385A (en) * 1997-02-11 2000-11-14 Smith & Nephew, Inc. Repairing cartilage
US7087227B2 (en) * 1997-04-04 2006-08-08 Barnes-Jewish Hospital Cartilage composites and methods of use
USRE41286E1 (en) * 1997-08-14 2010-04-27 Zimmer Orthobiologics, Inc. Compositions for regeneration and repair of cartilage lesions
USRE39587E1 (en) * 1998-02-27 2007-04-24 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
USRE38522E1 (en) * 1998-02-27 2004-05-25 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
US6056777A (en) * 1998-02-27 2000-05-02 Mcdowell; Charles L. Method and device for regenerating cartilage in articulating
US6849255B2 (en) * 1998-08-18 2005-02-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for enhancing cartilage repair
US6451060B2 (en) * 1999-03-01 2002-09-17 Rush-Presbyterian-St. Luke's Medical Center Cartilage matrix and in vitro production of transplantable cartilage tissue
US6197061B1 (en) * 1999-03-01 2001-03-06 Koichi Masuda In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6579538B1 (en) * 1999-12-22 2003-06-17 Acell, Inc. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
US6576265B1 (en) * 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
US6371958B1 (en) * 2000-03-02 2002-04-16 Ethicon, Inc. Scaffold fixation device for use in articular cartilage repair
US20090248592A1 (en) * 2000-10-20 2009-10-01 Reinhold Schmieding Method of selling procedure specific allografts and associated instrumentation
US7548865B2 (en) * 2000-10-20 2009-06-16 Arthrex, Inc. Method of selling procedure specific allografts and associated instrumentation
US20040107003A1 (en) * 2001-02-28 2004-06-03 Synthes (Usa) Demineralized bone implants
US20030077821A1 (en) * 2001-09-15 2003-04-24 Sah Robert L. Methods to engineer stratified cartilage tissue
US20040127987A1 (en) * 2002-06-13 2004-07-01 Evans Douglas G. Devices and methods for treating defects in the tissue of a living being
US7824701B2 (en) * 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
USRE42208E1 (en) * 2003-04-29 2011-03-08 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7475257B2 (en) * 2003-09-25 2009-01-06 International Business Machines Corporation System and method for selecting and using a signal processor in a multiprocessor system to operate as a security for encryption/decryption of data
US7875296B2 (en) * 2003-11-26 2011-01-25 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US20110052705A1 (en) * 2004-03-08 2011-03-03 Malinin Theodore I Cartilage composition and process for producing the cartilage composition
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US20090324722A1 (en) * 2004-09-22 2009-12-31 Elisseeff Jennifer H Cartilage filling device
US7901451B2 (en) * 2004-09-24 2011-03-08 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US7273756B2 (en) * 2004-10-01 2007-09-25 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US20110070271A1 (en) * 2004-10-12 2011-03-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20060293757A1 (en) * 2005-06-22 2006-12-28 Mckay William F Osteograft treatment to promote osteoinduction and osteograft incorporation
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US20080058953A1 (en) * 2006-08-31 2008-03-06 Scarborough Nelson L Demineralized cancellous strip DBM graft
US20080153157A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080249632A1 (en) * 2007-02-26 2008-10-09 Biomet Sports Medicine, Inc. Stable cartilage defect repair plug
US20110104242A1 (en) * 2007-05-10 2011-05-05 Malinin Theodore I Cartilage material
US20080294270A1 (en) * 2007-05-24 2008-11-27 Zimmer Orthobiologics, Inc. Differentially processed tissue and processing methods thereof
US20090024224A1 (en) * 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43258E1 (en) 2003-04-29 2012-03-20 Musculoskeletal Transplant Foundation Glue for cartilage repair
US8292968B2 (en) 2004-10-12 2012-10-23 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US9701940B2 (en) 2005-09-19 2017-07-11 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8906110B2 (en) 2007-01-24 2014-12-09 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US9808558B2 (en) 2008-11-20 2017-11-07 Allosource Allografts combined with tissue derived stem cells for bone healing
US9814803B2 (en) 2008-11-20 2017-11-14 Allosource Allografts combined with tissue derived stem cells for bone healing
CN102078642A (en) * 2011-01-19 2011-06-01 北京大学第三医院 Articular cartilage restoration and regeneration stent and preparation method thereof
US9364328B2 (en) 2011-11-17 2016-06-14 Allosource Multi-piece machine graft systems and methods
US11123193B2 (en) 2013-02-22 2021-09-21 Allosource Cartilage mosaic compositions and methods
US10335281B2 (en) 2013-02-22 2019-07-02 Allosource Cartilage mosaic compositions and methods
US9289452B2 (en) 2013-03-07 2016-03-22 Allosource Consistent calcium content bone allograft systems and methods
US9486556B2 (en) 2013-03-07 2016-11-08 Allosource Consistent calcium content bone allograft systems and methods
US9603710B2 (en) 2013-03-15 2017-03-28 Allosource Methods of manufacturing perforated osteochondral allograft compositions
US11229725B2 (en) 2013-03-15 2022-01-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US9730796B2 (en) 2014-05-16 2017-08-15 Allosource Composite bone constructs and methods
US10617526B2 (en) 2014-05-16 2020-04-14 Allosource Composite bone constructs and methods
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US11555172B2 (en) 2014-12-02 2023-01-17 Ocugen, Inc. Cell and tissue culture container
US11452796B2 (en) 2017-06-30 2022-09-27 Allosource Cellular bone grafts, and methods of manufacture and use

Also Published As

Publication number Publication date
US7815926B2 (en) 2010-10-19
US20070009610A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
US7815926B2 (en) Implant for articular cartilage repair
US20170304058A1 (en) Implant for Repairing a Cartilage Defect
US8183042B2 (en) Multi-layered implant prepared by a method of tissue repair using a multi-layered matrix
US8795361B2 (en) Osteochondral plug graft, kit and method
US7427293B2 (en) Osteochondral plug graft, kit and method
EP2338441B1 (en) Particulate cartilage system
US8221500B2 (en) Cartilage allograft plug
JP2858782B2 (en) Production of articular cartilage and bone regenerating composition, skeletal tissue transplant, and method of regenerating skeletal tissue
US7837740B2 (en) Two piece cancellous construct for cartilage repair
US6884621B2 (en) Method and carrier for culturing multi-layer tissue in vitro
US20080274157A1 (en) Cartilage implant plug with fibrin glue and method for implantation
US20050222687A1 (en) Cartilage implant assembly and method for implantation
US20010018614A1 (en) Implants for orthopedic applications
US20170112968A1 (en) Cell bandage
CN101417151A (en) Biology source type calcified-layer containing cartilage tissue engineer bracket
Delloye et al. Impaction bone grafting in revision arthroplasty
Kheir et al. Management of articular cartilage defects
AU693323B2 (en) Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
AU693323C (en) Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
EP1181060A1 (en) Molded implants for orthopedic applications

Legal Events

Date Code Title Description
AS Assignment

Owner name: MUSCULOSKELETAL TRANSPLANT FOUNDATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VON VERSEN, RUDIGER WALTER ARTHUR;REEL/FRAME:024033/0928

Effective date: 20081110

Owner name: MUSCULOSKELETAL TRANSPLANT FOUNDATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SYRING, CARINA;REEL/FRAME:024033/0924

Effective date: 20090905

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION